NeoCore Technology Co., Ltd. (TPEX:4131)

Market Cap	1.34B +4.1%
Revenue (ttm)	235.54M +104.2%
Net Income	-20.42M
EPS	-0.52
Shares Out	39.79M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	305,233
Open	34.40
Previous Close	33.90
Day's Range	33.60 - 34.40
52-Week Range	30.10 - 42.45
Beta	-0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About NeoCore Technology

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company’s products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and cha...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1987
• Employees: 44
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4131

Financial Performance

In 2025, NeoCore Technology's revenue was 244.66 million, an increase of 297.52% compared to the previous year's 61.55 million. Losses were -30.87 million, -35.87% less than in 2024.